$0.88 -0.05 (-4.89%)
11/6/2009 3:59 PM

GenVec, Inc. (GNVC)

CAPS Rating: 3 out of 5

A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.

Current Price $0.88 Mkt Cap $86.52M
Open $0.90 P/E Ratio 0.00
Prev. Close $0.93 Div. (Yield) N/A (N/A)
Daily Range $0.85 - $0.94 Volume 1,809,076
52-Wk Range $0.01 - $1.29 Avg. Daily Vol. 2,157,000

GNVC News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

256 Outperform
11 Underperform
 

All-Star Members

42 Outperform
3 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top GNVC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Sqwii (< 20)
Submitted June 01, 2008

In recent clincal trials, Genvec's leading drug TNFerade (TM) has received very encouraging results for head,neck & esophageal cancers. For more information, please go to the companys web site: www.genvec.com The target price of $20.00 could be… More

adbb (< 20)
Submitted April 14, 2007

Went up too fast. Wait a few months until it consolidates down in the $2 range.

GNVC VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about GNVC.

Recs

2
Member Avatar Sqwii (< 20) Submitted: 6/1/2008 3:16:21 PM : Outperform Start Price: $1.80 GNVC Score: -30.57

In recent clincal trials, Genvec's leading drug TNFerade (TM) has received very encouraging results for head,neck & esophageal cancers. For more information, please go to the companys web site: www.genvec.com The target price of $20.00 could be met from one month to within three years.

Recs

0
Member Avatar slaveofthegov (53.25) Submitted: 5/30/2008 10:56:49 AM : Outperform Start Price: $1.79 GNVC Score: -30.04

Got in with real money at 1.75 based on what they have in the pipeline.

Recs

1
Member Avatar kporter007 (23.16) Submitted: 2/27/2008 10:30:50 AM : Outperform Start Price: $2.84 GNVC Score: -42.55

They are in third phase trials for their main product which had promising results last year. This year they got the FDA to allow them to change the wording of the goal of the trials from 12month survival rate to overall survival rate, which is much more in line with their initial results (which showed a 10 month survival increase if I remember correctly). This should allow their trials to be successful and streamline FDA approval.

They also inked a deal with a UK company to mass produce the Adenovector that is their main product. This shows me that they are expecting approval for the pancreatic treatment and are getting everything ready to roll out the product.

This same treatment is also being tested for other types of cancers.

They also have contracts with government and world organizations for vaccines for malaria and AIDS, plus are developing a treatment for hearing and balance loss.

I think that if (and I suspect it will) their first product for pancreatic cancer is approved and starts to sell, then the other cancer treatments will not be far behind.

I bought this in the $3 range (I have lost 50%), but it is a long hold. I expect to start seeing a turn around towards the end of summer 08, with a large increase in the 1st quarter 09 based on when I believe approval and manufacturing will begin.

Leaderboard

Find the members with the highest scoring picks in GNVC.

Score Leader

opies

opies (83.21) Score: +88.20

The Score Leader is the member with the highest score across all their picks in GNVC.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
Calypso325 90.23 4/13/2007 Underperform 3W $4.05 -78.28% -21.83% +56.45
adbb < 20 4/16/2007 Underperform 1Y $4.13 -78.70% -22.33% +56.36 1 Comment
stockerace 97.46 3/6/2007 Underperform 3W $2.72 -67.65% -18.08% +49.58
Ihavegas 76.94 6/12/2007 Underperform 5Y $2.80 -68.58% -24.83% +43.75
WSPFan 58.11 6/12/2007 Underperform 3Y $2.80 -68.58% -24.83% +43.75
klzam4 < 20 8/14/2007 Underperform 3M $2.60 -66.16% -22.60% +43.56
rimmereide < 20 6/20/2007 Underperform NS $2.81 -68.69% -25.83% +42.86
Stockkid88 43.81 12/20/2006 Underperform 3W $2.16 -59.27% -20.09% +39.18
DavidHarvey2007 69.73 6/29/2007 Underperform 3M $2.44 -63.94% -25.26% +38.68
johnnybb < 20 5/5/2008 Underperform 3Y $1.95 -54.88% -21.23% +33.65

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackMerriman < 20 5/22/2007 Outperform NS $4.55 -80.66% -25.83% -54.84
TrackBoenning < 20 4/23/2007 Outperform NS $4.21 -79.10% -23.73% -55.37
TrackFerrisBaker 72.41 1/4/2007 Outperform NS $2.50 -64.81% -19.49% -45.32

Featured Broker Partners